Identification of CHEK2 germline mutations in BRCA1/2 and PALB2 negative breast and ovarian cancer patients
Conclusion: The present study may shed light on alternative variations that could be significant for understanding the prevalence and clinical suitability of the CHEK2 gene.
Source: Human Heredity - Category: Genetics & Stem Cells Source Type: research
More News: Breast Cancer | Cancer | Cancer & Oncology | Gastroschisis Repair | Genetics | Ovarian Cancer | Ovaries | Study | Turkey Health | Women